Today's Dr. Pourhassan Interactive was reassuring
Post# of 148300
• The death was after the day 14 results were recorded. It is irrelevant at this point if it was in the Leronlimab or placebos group. However, even if this had happened before this likely would not affect the results if the cause was uncorrelated with administration of whatever injection.
• For the conspiracy theorists, the only reason for the delay was that the bio-statistician requested more time.
• There will be a time-lapse analysis of the data. That is Day 0-3-7-14. In a word: progression analysis
• NP is optimistic about the outcome (and we should be). The data safety data suggests that the Leronlimab group will have better outcomes than the placebo group as less patients progressed to severe conditions as measured by SAE.
So, when will be that data released?? I am not sure but my working theory at the moment is that they will wait to do a double-whammy with the DSCM S/C report. But I can be wrong and NP might release as soon as available (few days). Either case expect a step SP increase.
And last but no least it was refreshing to see Christine’s smile once more.